We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
29 January 2021
RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company with its lead compound RLF-100TM (Aviptadil) in advanced clinical development to treat severe COVID-19 patients, has signed a binding term sheet to acquire all shares in AdVita Lifescience GmbH ("AdVita"), a Germany-based, privately held pharmaceutical company de-veloping effective products and strategies to improve the treatment and diagnosis of rare lung diseases, in exchange for EUR 25m of Relief common shares, plus possible future contingent milestone payments of up to EUR 20m. The closing of the transaction is subject to customary closing conditions as well as legal and securities regulatory approvals and is expected to occur in Q2 2021. VISCHER advises Relief as lead counsel and regarding the Swiss legal aspects of this transaction whereas K&L Gates acts as German counsel and Sterne Kessler as US IP counsel. The VISCHER team led by partner Dr. Robert Bernet (Corporate/M&A) comprises Dr. Peter Kühn (Counsel, Corporate/M&A), Florian Kambor (Junior Associate, Corporate/M&A) and Christian Wyss (Partner, IP).
Press release
Categories: Mergers & Acquisitions, Deals & Cases
Attorney at Law
The software company Infosim GmbH & Co. KG, based in Würzburg, a leading international provider of...
Bernet, Robert / Kühn, Peter, Wer trägt die Finanzierungsverantwortung?, WEKA Business Media AG, Nr....
RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFFD, RLFTD) ("Relief") has entered into has...